As of April 2025, CSL, Australia's leading biotechnology firm, is proactively addressing potential U.S. pharmaceutical tariffs introduced by the Trump administration. These tariffs are part of broader protectionist measures targeting countries with perceived "unfair" trade practices, including Australia's Pharmaceutical Benefits Scheme (PBS).
Contact Information
View larger map
Adelaide Office: Level 30, 91 King William Street, CBD, Adelaide, SA
Tel:+61- 871343220
Level 30, 91 King William Street, CBD, Adelaide, SA